Adherence to Antiseizure Medications Around Pregnancy
Evidence-based care for people with epilepsy of childbearing potential (PWECP) who become pregnant includes prescribing antiseizure medications (ASMs) to minimize seizure frequency while limiting teratogenic exposures (i.e., valproate, topiramate). We aimed to examine peripartum ASM discontinuation and adherence among PWECP; and whether patients seen by high-volume epilepsy providers have different teratogenic ASM exposure.
Authors
- Kevin A. Kerber (ORCID: https://orcid.org/0000-0002-4722-8307)
- James Francis Burke (ORCID: https://orcid.org/0000-0002-2296-1588)
- Seuli Brill
- Chun Chieh Lin
- Sarita Maturu (ORCID: https://orcid.org/0000-0003-3242-7255)
- Amanda V. Gusovsky Chevalier
Institutions
- Columbus State Community College (US)
- Columbus State University (US)
- The Ohio State University Wexner Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- Neurology Open Access
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1212/wn9.0000000000000070
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00